Literature DB >> 19049292

Preventive effects of nutritional doses of polyphenolic molecules on cardiac fibrosis associated with metabolic syndrome: involvement of osteopontin and oxidative stress.

Thibault Sutra1, Catherine Oiry, Jacqueline Azay-Milhau, Estelle Youl, Richard Magous, Pierre-Louis Teissèdre, Jean-Paul Cristol, Gérard Cros.   

Abstract

We previously showed that grape extracts enriched in different polyphenolic families were similarly able to prevent reactive oxygen species (ROS) production, although having differential effects on various features of metabolic syndrome when administered at a dose of 21 mg/kg to the fructose (60%)-fed rat (a model of metabolic syndrome). In the present work, we analyzed on the same model the effect of pure polyphenolic molecules (catechin, resveratrol, delphinidin, and gallic acid) administered at a dose of 2.1 mg/kg. Delphinidin and gallic acid prevented insulin resistance, while gallic acid prevented the elevation of blood pressure. All molecules prevented cardiac ROS overproduction and NADPH overexpression. We also showed that fructose feeding was associated with cardiac fibrosis (accumulation of collagen I) and expression of osteopontin, a factor induced by ROS and a collagen I expression inducer. Collagen I and osteopontin expressions were prevented by the administration of all polyphenolic molecules. The potential use of polyphenols in the prevention of cardiac fibrosis should be further explored.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049292     DOI: 10.1021/jf802357g

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  12 in total

Review 1.  Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?

Authors:  Renu Agarwal; Puneet Agarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-23

2.  Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease.

Authors:  Kinan Rahal; Phyllissa Schmiedlin-Ren; Jeremy Adler; Muhammad Dhanani; Victoria Sultani; Ahren C Rittershaus; Laura Reingold; Ji Zhu; Barbara J McKenna; Gregory M Christman; Ellen M Zimmermann
Journal:  Inflamm Bowel Dis       Date:  2011-08-29       Impact factor: 5.325

3.  Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cells.

Authors:  Patricia Garcia; Phyllissa Schmiedlin-Ren; Jason S Mathias; Huaijing Tang; Gregory M Christman; Ellen M Zimmermann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-03       Impact factor: 4.052

4.  Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts.

Authors:  Ping Li; Mei-Lan Liang; Ying Zhu; Yao-Yao Gong; Yun Wang; Ding Heng; Lin Lin
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 5.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 6.  Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis.

Authors:  Sedigheh Asgary; Raheleh Karimi; Saeideh Momtaz; Rozita Naseri; Mohammad Hosein Farzaei
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 7.  What is new for an old molecule? Systematic review and recommendations on the use of resveratrol.

Authors:  Ole Vang; Nihal Ahmad; Clifton A Baile; Joseph A Baur; Karen Brown; Anna Csiszar; Dipak K Das; Dominique Delmas; Carmem Gottfried; Hung-Yun Lin; Qing-Yong Ma; Partha Mukhopadhyay; Namasivayam Nalini; John M Pezzuto; Tristan Richard; Yogeshwer Shukla; Young-Joon Surh; Thomas Szekeres; Tomasz Szkudelski; Thomas Walle; Joseph M Wu
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

Review 8.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

9.  Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat.

Authors:  Bolanle C Akinwumi; Pema Raj; Danielle I Lee; Crystal Acosta; Liping Yu; Samuel M Thomas; Kalyanam Nagabhushanam; Muhammed Majeed; Neal M Davies; Thomas Netticadan; Hope D Anderson
Journal:  Molecules       Date:  2017-02-01       Impact factor: 4.411

10.  Relaxin and atrial natriuretic peptide pathways participate in the anti-fibrotic effect of a melon concentrate in spontaneously hypertensive rats.

Authors:  Julie Carillon; Audrey Gauthier; Sandy Barial; Michel Tournier; Nathalie Gayrard; Anne-Dominique Lajoix; Bernard Jover
Journal:  Food Nutr Res       Date:  2016-04-12       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.